| Product Information |
|
| Registration Number |
DRP-14931
|
| Generic Name |
Bortezomib
|
| Brand Name |
Bortewell
|
| Dosage Strength |
3.5 mg
|
| Dosage Form |
Lyophilized Powder for Solution for Injection (IV/SC)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Antineoplastic Agent (Proteasome Inhibitor)
|
| Packaging |
8 mL-capacity USP Type I clear and colorless glass vial sealed with grey 20-D2 lyophilization bromobutyl rubber stopper for injection and aluminum seal with blue plastic flip-off cap (Box of 1's)
|
| Manufacturer |
Jiangsu Hanson Pharmaceutical Co. Ltd.
|
| Country of Origin |
China
|
| Trader |
|
| Importer |
Ambicare Pharmaceuticals Inc.
|
| Distributor |
Ambicare Pharmaceuticals Inc.
|
| Application Type |
Initial
|
| Issuance Date |
14 February 2024
|
| Expiry Date |
14 February 2029
|